Innovating Works
FLAMIN-GO: From pathobioLogy to synoviA on chip driving rheuMatoId arthritis to the precisioN medicine GOal INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-NMBP-TR-IND-2018-2020 FLAMIN-GO aims at developing an Organ-on-Chip technology for clinical trials on Rheumatoid Arthritis (RA). In RA, a number of unmet needs st...
2020-11-06 - 2025-06-30 | Financiado
ASTROTECH: Disruptive materials technologies approaches to unravel the role of Astrocytes in brain function... INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-MSCA-ITN-2020 The past four decades demonstrated that non-neuronal cells, called astrocytesare emerging as crucial players for brain function & dysfunctio...
2020-09-04 - 2025-04-30 | Financiado
CARTHAGO: Cartilaginous tissue regeneration by non viral gene therapy taking the hurdles towards efficient de... INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-MSCA-ITN-2020 Chronic low back pain due to intervertebral disc (IVD) degeneration and osteoarthritis (OA) worldwide impact human health and well-being due...
2020-09-02 - 2024-08-31 | Financiado
MOBILIsE: Molecular Bioengineering in health ERA chair INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA tramitó un H2020: H2020-WIDESPREAD-2018-2020 MOBILIsE aims to recruit an outstanding Researcher to act as the ERA Chair Holder to the National Institute of Biomedical Engineering (INEB)...
2020-06-19 - 2026-06-30 | Financiado
PREMUROSA: Precision medicine for muscoloskeletal regeneration prosthetics and active ageing INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-MSCA-ITN-2019 Muscoloskeletal diseases are a major burden on individuals, healthcare and welfare systems. Treatment of muscolo-skeletal disorders is curre...
2019-08-09 - 2024-09-30 | Financiado
RESTORE: User centred smart nanobiomaterial based 3D matrices for chondral repair INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA tramitó un H2020: H2020-NMBP-TR-IND-2018-2020 The RESTORE project aims at developing an effective approach to manage the specific unmet clinical needs to treat knee chondral lesions. RES...
2018-12-12 - 2022-08-31 | Financiado
BonePainII: A European Training Network to Combat Bone Pain INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-MSCA-ITN-2018 In Europe 20 - 30% of adults are affected at any one time by musculoskeletal pain such as arthritic pain, lower back pain, pain from osteopo...
2018-08-20 - 2022-12-31 | Financiado
MIRACLE: Mid infrared arthroscopy innovative imaging system for real time clinical in depth examination and d... INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-ICT-2016-2017 MIRACLE will take towards commercialization the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage en...
2017-12-19 - 2022-03-31 | Financiado
mCBEEs: Advanced integrative solutions to Corrosion problems beyond micro scale towards long term durabilit... INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un H2020: H2020-MSCA-ITN-2017 MCBEEs Innovative Training Network is a joint venture between academy and industry with a primary goal to train young researchers in the fie...
2017-08-14 - 2021-09-30 | Financiado
SCIREGENASENSE: TARGETED DELIVERY OF NEW ANTISENSE MOLECULES FOR REGENERATION ENHANCEMENT AFTER SPINAL CORD INJURY INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA tramitó un FP7: "Spinal cord injury (SCI) leads to severe physical and psychological damages. Classical pharmacotherapeutics have had limited success to tre...
Financiado
IB2: Industrial Biological Biomaterials Doctorate INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA tramitó un FP7: The present proposal consists in an elite doctorate program designed to train PhD candidates at the highest academic level in combination wi...
Financiado
DISC REGENERATION: Novel biofunctional high porous polymer scaffolds and techniques controlling angiogenesis for the re... INEBINSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA participó en un FP7: 30% of European workers experience back pain, and it is the most frequently reported work-related disorder. The proposed work seeks to provi...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.